BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30806860)

  • 1. Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Watanabe Y; Miyoshi N; Fujino S; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Doki Y; Mori M; Mizushima T
    Dig Dis Sci; 2019 Aug; 64(8):2280-2285. PubMed ID: 30806860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crohn's disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study.
    Elriz K; Palascak-Juif V; Joly F; Seguy D; Beau P; Chambrier C; Boncompain M; Fontaine E; Laharie D; Savoye G; Lerebours E
    Aliment Pharmacol Ther; 2011 Oct; 34(8):931-40. PubMed ID: 21848855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and Prognosis of Intestinal Failure in Crohn's Disease: An 18-year Experience From a National Centre.
    Soop M; Khan H; Nixon E; Teubner A; Abraham A; Carlson G; Lal S
    J Crohns Colitis; 2020 Nov; 14(11):1558-1564. PubMed ID: 32215559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of intestinal failure in Crohn's disease.
    Agwunobi AO; Carlson GL; Anderson ID; Irving MH; Scott NA
    Dis Colon Rectum; 2001 Dec; 44(12):1834-7. PubMed ID: 11742170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for urolithiasis in patients with Crohn's disease.
    Miyajima S; Ishii T; Watanabe M; Ueki T; Tanaka M
    Int J Urol; 2021 Feb; 28(2):220-224. PubMed ID: 33191551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat intestinal resections increase the risk of recurrence of Crohn's disease.
    Riss S; Schuster I; Papay P; Mittlböck M; Stift A
    Dis Colon Rectum; 2013 Jul; 56(7):881-7. PubMed ID: 23739195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor therapy decreases the risk of initial intestinal surgery after diagnosis of Crohn's disease of inflammatory type.
    Nagata Y; Esaki M; Moriyama T; Hirano A; Umeno J; Maehata Y; Torisu T; Matsumoto T; Kitazono T
    J Gastroenterol; 2019 Apr; 54(4):330-338. PubMed ID: 30244398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery.
    Sato Y; Matsui T; Yano Y; Tsurumi K; Okado Y; Matsushima Y; Koga A; Takahashi H; Ninomiya K; Ono Y; Takatsu N; Beppu T; Nagahama T; Hisabe T; Takaki Y; Hirai F; Yao K; Higashi D; Futami K; Washio M
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1713-9. PubMed ID: 26094852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
    Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
    Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
    Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and frequent histological recurrence of Crohn's disease in small intestinal allografts.
    Harpaz N; Schiano T; Ruf AE; Shukla D; Tao Y; Fishbein TM; Sauter BV; Gondolesi GE
    Transplantation; 2005 Dec; 80(12):1667-70. PubMed ID: 16378058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence rates and an evaluation of reported risk factors for osteonecrosis (avascular necrosis) in Crohn's disease.
    Freeman HJ; Freeman KJ
    Can J Gastroenterol; 2000 Feb; 14(2):138-43. PubMed ID: 10694287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-α antibodies improve intestinal barrier function in Crohn's disease.
    Noth R; Stüber E; Häsler R; Nikolaus S; Kühbacher T; Hampe J; Bewig B; Schreiber S; Arlt A
    J Crohns Colitis; 2012 May; 6(4):464-9. PubMed ID: 22398062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
    Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
    Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres.
    Lee MJ; Freer C; Adegbola S; Elkady S; Parkes M; Hart A; Fearnhead NS; Lobo AJ; Brown SR
    Colorectal Dis; 2018 Sep; 20(9):797-803. PubMed ID: 29569419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
    BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of anti-TNF alpha antibodies in treatment of fistulizing Crohn's disease].
    Rozpondek P; Zwolińska-Wcisło M; Przybylska M; Mach T
    Przegl Lek; 2011; 68(9):602-5. PubMed ID: 22335009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.